drug

alirocumab

1 story · latest Jul 30, 2026

Status: FDA approved Jul 2015 · BLA125559
Brand: Praluent
Codes: REGN727, SAR236553
Trials: 4 registered trials in coverage

Relationships

Developed by Regeneron Pharmaceuticals

Timeline

Sanofi registers alirocumab cardiovascular outcomes study; RSV+HMPV vaccine trial recruiting

Jul 30Weekly roundup, 3 itemsalirocumab Sanofi

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.